Zanoteli Edmar, van de Vlekkert Diantha, Bonten Erik J, Hu Huimin, Mann Linda, Gomero Elida M, Harris A John, Ghersi Giulio, d'Azzo Alessandra
Department of Genetics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Biochim Biophys Acta. 2010 Jul-Aug;1802(7-8):659-72. doi: 10.1016/j.bbadis.2010.04.002. Epub 2010 Apr 11.
Neuraminidase 1 (NEU1) regulates the catabolism of sialoglycoconjugates in lysosomes. Congenital NEU1 deficiency in children is the basis of sialidosis, a severe neurosomatic disorder in which patients experience a broad spectrum of clinical manifestations varying in the age of onset and severity. Osteoskeletal deformities and muscle hypotonia have been described in patients with sialidosis. Here we present the first comprehensive analysis of the skeletal muscle pathology associated with loss of Neu1 function in mice. In this animal model, skeletal muscles showed an expansion of the epimysial and perimysial spaces, associated with proliferation of fibroblast-like cells and abnormal deposition of collagens. Muscle fibers located adjacent to the expanded connective tissue underwent extensive invagination of their sarcolemma, which resulted in the infiltration of the fibers by fibroblast-like cells and extracellular matrix, and in their progressive cytosolic fragmentation. Both the expanded connective tissue and the juxtaposed infiltrated muscle fibers were strongly positive for lysosomal markers and displayed increased proteolytic activity of lysosomal cathepsins and metalloproteinases. These combined features could lead to abnormal remodeling of the extracellular matrix that could be responsible for sarcolemmal invagination and progressive muscle fiber degeneration, ultimately resulting in an overt atrophic phenotype. This unique pattern of muscle damage, which has never been described in any myopathy, might explain the neuromuscular manifestations reported in patients with the type II severe form of sialidosis. More broadly, these findings point to a potential role of NEU1 in cell proliferation and extracellular matrix remodeling.
神经氨酸酶1(NEU1)调节溶酶体中唾液酸糖缀合物的分解代谢。儿童先天性NEU1缺乏是涎酸沉积症的基础,涎酸沉积症是一种严重的神经躯体疾病,患者会出现广泛的临床表现,发病年龄和严重程度各不相同。涎酸沉积症患者已出现骨骼畸形和肌张力减退。在此,我们首次对小鼠中与Neu1功能丧失相关的骨骼肌病理学进行了全面分析。在这个动物模型中,骨骼肌显示肌外膜和肌束膜间隙扩大,伴有成纤维细胞样细胞增殖和胶原蛋白异常沉积。位于扩张结缔组织附近的肌纤维其肌膜广泛内陷,导致成纤维细胞样细胞和细胞外基质浸润到纤维中,并使其胞质逐渐碎片化。扩张的结缔组织和并列的浸润肌纤维对溶酶体标记物均呈强阳性,并显示溶酶体组织蛋白酶和金属蛋白酶的蛋白水解活性增加。这些综合特征可能导致细胞外基质异常重塑,这可能是肌膜内陷和进行性肌纤维变性的原因,最终导致明显的萎缩表型。这种独特的肌肉损伤模式在任何肌病中都未曾描述过,可能解释了II型严重涎酸沉积症患者报告的神经肌肉表现。更广泛地说,这些发现指出了NEU1在细胞增殖和细胞外基质重塑中的潜在作用。